Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

In addition to the scientific meeting, featuring twelve international plenary speakers, along with open papers and poster sessions, there will be two satellite events on Sunday 7 September - a hands-on clinical workshop on tendinopathy and a consensus meeting on outcome measures.

The meeting has proved highly popular and is now fully booked, but you can follow the meeting and join the discussion on Twitter using hashtag #Tendons2014.

The Symposium is co-chaired by NDORMS Head of Department Professor Andrew Carr, Associate Professor Philippa Hulley, also of NDORMS and Associate Professor Mark Thompson, of the Institute of Biomedical Engineering, Oxford.

Speaking of the event, Prof Thompson says: "ISTS 2014 will pull together exciting plenary speakers, excellent scientists and expert clinicians in the inspiring surroundings of St Hilda's College to find new ways of treating painful and debilitating tendon disease. The meeting venue is full, but social media will take the conversations wider and further, and we will be posting video of the final discussion session."

The meeting proceedings will be published in the BJSM soon after the event.

For the first time in its three-edition history, the meeting is co-sponsored by the International Symposium on Ligaments and Tendons, while the commercial sponsors are the British Journal of Sports Medicine (BJSM), UTC Imaging BV, TRB Chemedica, Biomet, Mathys, RegenLab and Bose.

Prof Thompson has already spoken to BJSM about this year's Symposium and a podcast is online. This year's programme is also published.

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.